The risk of malignancy in patients with dermatomyositis and polymyositis

Alan N. Baer, Robert L. Wortmann

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Dermatomyositis is associated with an underlying malignancy in approximately 25% of patients. A weaker association is evident for polymyositis. The underlying malignancy is usually an adenocarcinoma of the ovary, lung, or gastrointestinal tract. Patients with dermatomyositis or polymyositis need to be evaluated uniformly for an underlying malignancy at the time of initial diagnosis and, in some cases, in the event of a subsequent recurrence. This apparent paraneoplastic syndrome may stem from an immune reaction to antigens expressed in cancer cells that crosses over to the same antigens expressed by regenerating fibers in damaged or diseased muscle.

Original languageEnglish (US)
Title of host publicationThe Inflammatory Myopathies
PublisherHumana Press
Pages307-318
Number of pages12
ISBN (Print)9781603278287
DOIs
StatePublished - Jan 1 2009

Keywords

  • Dermatomyositis
  • Malignancy
  • Paraneoplastic syndrome
  • Polymyositis

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The risk of malignancy in patients with dermatomyositis and polymyositis'. Together they form a unique fingerprint.

  • Cite this

    Baer, A. N., & Wortmann, R. L. (2009). The risk of malignancy in patients with dermatomyositis and polymyositis. In The Inflammatory Myopathies (pp. 307-318). Humana Press. https://doi.org/10.1007/978-1-60327-827-0_17